Leaflet JAXTERAN 240mg gastro-resistant capsules

Product code:
W70563001
Quantity:
56
Indicated for:
multiple sclerosis
Route of administration:
oral
Substance:
dimethyl fumarate (immunomodulator)
ATC
L04AX07 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants

Precautions:

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Dimethyl fumarate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by reducing inflammation and protecting nerve cells from oxidative stress.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of adverse effects.

Side effects may include flushing, nausea, diarrhea, abdominal pain, or a decrease in lymphocyte count. In rare cases, severe allergic reactions or progressive multifocal leukoencephalopathy may occur.

Dimethyl fumarate is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about JAXTERAN 240mg

Substance:
dimethyl fumarate
Date of latest medicines list:
01-10-2024
Product code:
W70563001
Concentration:
240mg
Pharmaceutical form:
gastro-resistant capsules
Quantity:
56
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PHARMADOX HEALTHCARE LTD. - MALTA
Holder:
ZENTIVA, K.S. - REPUBLICA CEHA
Number:
15598/2024/01
Shelf life:
3 years

Pharmaceutical forms available for dimethyl fumarate

Concentrations available for dimethyl fumarate

  • 120mg
  • 240mg
  • 30mg